160 related articles for article (PubMed ID: 31437846)
1. Co-Deposition of IgM and C3 May Indicate Unfavorable Renal Outcomes in Adult Patients with Primary Focal Segmental Glomerulosclerosis.
Mirioglu S; Caliskan Y; Ozluk Y; Dirim AB; Istemihan Z; Akyildiz A; Yazici H; Turkmen A; Kilicaslan I; Sever MS
Kidney Blood Press Res; 2019; 44(5):961-972. PubMed ID: 31437846
[TBL] [Abstract][Full Text] [Related]
2. Clinical Significance of IgM and C3 Glomerular Deposition in Primary Focal Segmental Glomerulosclerosis.
Zhang YM; Gu QH; Huang J; Qu Z; Wang X; Meng LQ; Wang F; Liu G; Cui Z; Zhao MH
Clin J Am Soc Nephrol; 2016 Sep; 11(9):1582-1589. PubMed ID: 27340287
[TBL] [Abstract][Full Text] [Related]
3. IgM as a novel predictor of disease progression in secondary focal segmental glomerulosclerosis.
Pačić A; Šenjug P; Bacalja J; Tišljar M; Horvatić I; Bulimbašić S; Knotek M; Galešić K; Galešić Ljubanović D
Croat Med J; 2017 Aug; 58(4):281-291. PubMed ID: 28857521
[TBL] [Abstract][Full Text] [Related]
4. IgM and C3 Deposition in Primary Focal Segmental Glomerulosclerosis (FSGS): A Clinical and Histopathological Spectrum.
Amer F; Syed M; Afzal A; Hussain M; Hassan U; Bashir S; Hameed M; Ishtiaq S
Cureus; 2023 Apr; 15(4):e37346. PubMed ID: 37182061
[TBL] [Abstract][Full Text] [Related]
5. Mesangial C4d deposition is independently associated with poor renal survival in patients with primary focal segmental glomerulosclerosis.
Heybeli C; Oktan MA; Yıldız S; Ünlü M; Celik A; Sarıoglu S
Clin Exp Nephrol; 2019 May; 23(5):650-660. PubMed ID: 30617839
[TBL] [Abstract][Full Text] [Related]
6. Serum C3 and Renal Outcome in Patients with Primary Focal Segmental Glomerulosclerosis.
Liu J; Xie J; Zhang X; Tong J; Hao X; Ren H; Wang W; Chen N
Sci Rep; 2017 Jun; 7(1):4095. PubMed ID: 28642464
[TBL] [Abstract][Full Text] [Related]
7. Focal segmental glomerulosclerosis, excluding atypical lesion, is a predictor of renal outcome in patients with membranous nephropathy: a retrospective analysis of 716 cases.
He HG; Wu CQ; Ye K; Zeng C; Huang YY; Luo SW; Yin W; Ye QR; Peng XM
BMC Nephrol; 2019 Aug; 20(1):328. PubMed ID: 31438882
[TBL] [Abstract][Full Text] [Related]
8. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
Markowitz GS; Schwimmer JA; Stokes MB; Nasr S; Seigle RL; Valeri AM; D'Agati VD
Kidney Int; 2003 Oct; 64(4):1232-40. PubMed ID: 12969141
[TBL] [Abstract][Full Text] [Related]
9. IgM contributes to glomerular injury in FSGS.
Strassheim D; Renner B; Panzer S; Fuquay R; Kulik L; Ljubanović D; Holers VM; Thurman JM
J Am Soc Nephrol; 2013 Feb; 24(3):393-406. PubMed ID: 23393315
[TBL] [Abstract][Full Text] [Related]
10. Severe glomerular C3 deposition indicates severe renal lesions and a poor prognosis in patients with immunoglobulin A nephropathy.
Wu J; Hu Z; Wang Y; Hu D; Yang Q; Li Y; Dai W; Zhu F; Yang J; Wang M; Zhu H; Liu L; He X; Han M; Yao Y; Pei G; Zeng R; Xu G
Histopathology; 2021 May; 78(6):882-895. PubMed ID: 33336446
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and outcomes of idiopathic membranous nephropathy with glomerular IgM deposits.
Yu-Zhu X; Na-Ya H; Ya-Gui Q; Xiong-Hui C; Zhi-Jian L; Wei C; Xin W
Clin Exp Med; 2022 Aug; 22(3):455-464. PubMed ID: 34698950
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of treatment failure and end-stage renal disease in familial focal segmental glomerular sclerosis.
Hao X; Xie J; Ma J; Wang Z; Zhou Q; Yang L; Pan X; Ren H; Chen N
Contrib Nephrol; 2013; 181():101-8. PubMed ID: 23689572
[TBL] [Abstract][Full Text] [Related]
13. The Clinical Impact of Glomerular Immunoglobulin M Deposition in Patients with Type 2 Diabetic Nephropathy.
Tang X; Li H; Li L; Zhang J; Xu H; Li L; Liu F
Am J Med Sci; 2018 Oct; 356(4):365-373. PubMed ID: 30360805
[TBL] [Abstract][Full Text] [Related]
14. An Outcomes-Based Definition of Proteinuria Remission in Focal Segmental Glomerulosclerosis.
Troost JP; Trachtman H; Nachman PH; Kretzler M; Spino C; Komers R; Tuller S; Perumal K; Massengill SF; Kamil ES; Oh G; Selewski DT; Gipson P; Gipson DS
Clin J Am Soc Nephrol; 2018 Mar; 13(3):414-421. PubMed ID: 29167190
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of glomerular IgM deposition in patients with lupus nephritis.
Wang F; Yu J; Zhang L; Zhang Y; Zhang J; Liu B; Yang X
BMC Immunol; 2021 Dec; 22(1):75. PubMed ID: 34876020
[TBL] [Abstract][Full Text] [Related]
16. [Factors predicting for renal survival in primary focal segmental glomerulosclerosis].
Roja JR; Pérez M; Hurtado A; Asato C
Nefrologia; 2008; 28(4):439-46. PubMed ID: 18662153
[TBL] [Abstract][Full Text] [Related]
17. Complement activation profile of patients with primary focal segmental glomerulosclerosis.
Huang J; Cui Z; Gu QH; Zhang YM; Qu Z; Wang X; Wang F; Cheng XY; Meng LQ; Liu G; Zhao MH
PLoS One; 2020; 15(6):e0234934. PubMed ID: 32569286
[TBL] [Abstract][Full Text] [Related]
18. Focal Segmental Glomerulosclerosis Superimposed on Transplant Glomerulopathy: Implications for Graft Survival.
Zhu Y; Fan Y; Xu F; Liang S; Liang D; Li P; Xia Y; Zhu X; Yang F; Chen J; Zeng C
Am J Nephrol; 2021; 52(10-11):788-797. PubMed ID: 34749369
[TBL] [Abstract][Full Text] [Related]
19. Is CD44 in glomerular parietal epithelial cells a pathological marker of renal function deterioration in primary focal segmental glomerulosclerosis?
Froes BP; de Almeida Araújo S; Bambirra EA; Oliveira EA; Simões E Silva AC; Pinheiro SVB
Pediatr Nephrol; 2017 Nov; 32(11):2165-2169. PubMed ID: 28799058
[TBL] [Abstract][Full Text] [Related]
20. Glomerular capillary C3 deposition as a risk factor for unfavorable renal outcome in pediatric primary focal segmental glomerular sclerosis.
Peng Y; Li B; Li X; Ju T; Zhang Z; Wang P; Sun T; Shu J; Wang M; Sun X; Chen H; Gao C; Xia Z
Front Pediatr; 2023; 11():1137375. PubMed ID: 37025292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
